About

Publications While At HealthPartners

Highlights

selected publications

Journal Article

Phase I dose-escalation study of procaspase-activating compound-1 in combination with temozolomide in patients with recurrent high-grade astrocytomas. 

Neurooncol Adv. 2023

Phase I study of procaspase-activating compound-1 (PAC-1) in the treatment of advanced malignancies. 

British Journal of Cancer. 2023

Contact

full name

M. Holdhoff

Quick Info

Publications

Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.

Collaboration

Co-author network

Map of science